Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;8(11):693.
doi: 10.21037/atm-20-3989.

COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon

Affiliations
Review

COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon

Giuseppe Lippi et al. Ann Transl Med. 2020 Jun.

Abstract

Coronavirus disease 2019 (COVID-19) pandemic has shocked the world and caused morbidity and mortality on an unprecedented level in the era of modern medicine. Evidence generated to-date on the virulence and pathogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suggests that COVID-19 may be considered a perfect storm, caused by a nature's virtually perfect biological weapon. This conclusion is supported by an updated analysis of pathogenesis and clinical progression of this infectious disease. It is now readily apparent that COVID-19 is not a clear-cut disorder, but is instead a gradually evolving pathology, characterized by a series of stages sustained by different molecular and biological mechanisms. The disease can hence be divided in at least five different phases (incubation, respiratory, pro-inflammatory, pro-thrombotic, and death or remission). Whilst the virus triggers direct cytopathic injury during the initial stage of illness, in the following evolving phases, it is the host itself that undergoes an almost suicidal reaction, sustained, amplified and maintained by the immune, complement and hemostatic systems. Another peculiar property making SARS-CoV-2 a devious and vicious pathogen is the biophysical structure of its receptor biding domain, which needs to be primed by human proteases, thus being less efficiently targetable by the host immune system. The unique pathophysiology of COVID-19 requires the customization of therapy by individual patient characteristics and according to the phase-specific, evolving derangement of the multiple biological pathways.

Keywords: Coronavirus disease 2019 (COVID-19); coagulation; coronavirus; inflammation; pathogenesis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-3989). GL serves as an unpaid executive editor-in-chief of Annals of Translational Medicine from Jan 2016 to Jan 2022. FSG serves as an unpaid editorial board member of Annals of Translational Medicine from Mar 2019 to Feb 2021. BMH has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Phases, clinical progression, management and available therapies of COVID-19. ARDS, acute respiratory distress syndrome; SIRS, severe inflammatory response syndrome.

References

    1. World Health Organization. Coronavirus disease (COVID-2019) situation reports. Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...
    1. Lippi G, Mattiuzzi C, Sanchis-Gomar F, et al. Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China. J Med Virol 2020. doi: .10.1002/jmv.25860 - DOI - PMC - PubMed
    1. Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020;55:105924. 10.1016/j.ijantimicag.2020.105924 - DOI - PMC - PubMed
    1. Istituto Superiore di Sanità. Integrated surveillance of COVID-19 in Italy. Available online: https://www.epicentro.iss.it/en/coronavirus/bollettino/Infografica_11mag...
    1. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med 2020;382:1177-9. 10.1056/NEJMc2001737 - DOI - PMC - PubMed